Skip to main content

Schiff Andrew N

No open-market purchases or sales filed in the past year.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
–
0 filings
Net
–
Bought minus sold
Companies
0
With open-market trades

Trades

Every Form 4 that lists Schiff Andrew N as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

ACRS Aclaris Therapeutics, Inc.

Director6 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 14, 2022 (view filing)Nov 10-144 daysSchiff Andrew NDirectorSSale−53.9K$17.05−$919.5K−11.0%434.5K after3 lots
Oct 26, 2022 (view filing)Oct 24-262 daysSchiff Andrew NDirectorSSale−41.2K$17.01−$700.5K−7.8%488.4K after3 lots
Oct 19, 2022 (view filing)Oct 17-182 daysSchiff Andrew NDirectorSSale−52.0K$16.57−$862.2K−8.9%529.6K after2 lots
Oct 11, 2022 (view filing)Oct 74 daysSchiff Andrew NDirectorSSale−7.32K$16.16−$118.4K−1.2%581.6K after
Oct 6, 2022 (view filing)Oct 4-62 daysSchiff Andrew NDirectorSSale−45.5K$16.45−$749.1K−7.2%588.9K after2 lots
Jun 21, 2022 (view filing)Jun 174 daysSchiff Andrew NDirectorSSale−19.6K$15.14−$296.2K−100.0%0 after

Elevation Oncology, Inc.

10% Owner1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 1, 2021 (view filing)6:29 PM ETJun 292 daysElms Steve and 4 othersDirector, Other: Managing MemberPPurchase+187.5K$16.00+$3.00M+7.1%2.83M after